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Abbreviations used in this document 
AXR:  Abdominal X-ray 
CT:  Computed Tomography 
RCT:  Randomized Controlled Trial 
SEMS: Self-Expanding Metallic Stent 
USA:  United States of America 
UK:  United Kingdom 
Definitions of terms used in this document 
Bridge to surgery: colonic stent is used as an interim 
measure for decompression and 
definitive surgery is undertaken 
electively at a later stage 
Decompression tubes: hollow tubes placed via the anus to 
allow decompression of the 
obstructed bowel and evacuation of 
faecal material 
Left-sided colonic obstruction: colonic obstruction distal to the 
hepatic flexure 
Level 1 evidence: evidence obtained from at least one 
properly designed randomized 
controlled trial 
Perforation: rupture of a hollow organ, in this case 
the large bowel, which manifests with 
an acute abdomen 
REFWORKS®: online bibliographic management 
programme that allows users to create 
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Right-sided colonic obstruction: obstruction proximal to and including 
the hepatic flexure 
Single stage surgery: tumour is resected and primary 
anastomosis performed at the first 
operation 
Stage the  patient: conduct screening investigations (i.e 
x-ray, ultrasound, computed 
tomography scans) to confirm or refute 
evidence of metastatic disease 
Stent:      self-expanding colonic metallic stent 
Stoma: surgically created opening in the 
intestine that allows the removal faecal 
material to drain into a collection 
device 
Two stage surgery: tumour is resected at first operation, 
proximal colon brought out as a 
stoma, and the rectal stump oversewn 
(Hartmann’s procedure). Stoma can be 
closed at a later stage 
Three stage surgery: 
First operation:   defunctioning loop colostomy; 
Second operation:  tumour resection and primary 
anastomosis done; 
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Declaration 
I, Dr C Warden, hereby declare that the work on which this dissertation/thesis 
is based is my original work (except where acknowledgements indicate 
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Dr C Warden, MBChB 
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Observatory, Cape Town, South Africa, 7925 
email: clairewarden@gmail.com 
Title 
Management of left-sided colonic obstruction: an audit of a stent based 
protocol 
Investigators 
C Warden, D Stupart, P Goldberg 
Introduction 
Despite improvements in medical and surgical care, patients presenting with 
colonic obstruction secondary to adenocarcinoma have mortality rates for 
emergency surgery of 15-20%.1 The immediate treatment priorities for these 
patients are fluid resuscitation and relief of the obstruction. Up until 1991, 
surgery was the only means of relieving colonic obstruction. Three forms of 
surgery have been used to relieve the obstruction including: single stage, two 
stage and three stage procedures*. It can be difficult to choose between 
simpler two or three staged operations that leave the patient with a stoma and 
single staged procedures that are technically demanding even for experienced 
colorectal surgeons. Colonic stenting offers a means of relieving the 
obstruction while avoiding the risks of surgery. 
In 1991 Dohmoto2 placed the first colonic stent and thus opened up a new 
avenue of treatment. Colonic stents have provided a way of decompressing 
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morbidity of a stoma. A review of the literature by Khot4 et al found that stents 
are successful at decompressing 92% of patients, 95% avoid stoma with a 1% 
mortality. Since 2004, the colorectal unit at Groote Schuur Hospital has treated 
left-sided obstructing colon cancers by endoscopic decompression using self-
expanding metal stents. 
Aim 
To determine the safety and efficacy of the colonic stent management protocol 
at Groote Schuur Hospital. (appendix A) 
Patients and Methods 
This is a retrospective audit of all patients who presented with left-sided 
colonic obstruction due to adenocarcinoma to the Colorectal Surgery Unit at 
Groote Schuur Hospital, Cape Town between January 2004 and June 2009. 
Patients with colonic obstruction due to other causes (eg volvulus, diverticular 
disease) are excluded from this study. Patients with signs of perforation will not 
form part of this study as they progress directly to surgery according to our 
current management protocol. Data will be collected from hospital folders for: 
patient gender, age, level of obstruction, stent success/failure, indication for 
stent (palliative or bridge to surgery), length of hospital stay, complications, 
stoma rate and mortality. Data will be entered into an excel spreadsheet for 
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Definitions 
Left-sided colonic obstruction: colonic obstruction distal to the hepatic 
flexure 
Stent:     self-expanding colonic metal stent 
Bridge to surgery: colonic stent is used as an interim measure 
for decompression and definitive surgery is 
undertaken electively at a later stage 
Perforation: rupture of a hollow organ, in this case the 
large bowel, which manifests with an acute 
abdomen 
*Single stage surgery: tumour is resected and primary anastomosis 
performed at the first operation 
*Two-stage surgery: tumour is resected at first operation, proximal 
colon brought out as a stoma, and the rectal 
stump over sewn (Hartmann’s procedure). 
Stoma can be closed at a later stage 
*Three-stage surgery: 
First operation:  defunctioning loop colostomy; 
Second operation: tumour resection and primary anastomosis 
done; 
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1 Introduction and Objectives 
The management of obstructing left-sided colorectal cancer presents a  
significant challenge to the surgeon.  Emergency surgery for acute malignant 
colonic obstruction is the current standard of care but is associated with 
significant morbidity and mortality. The concept of a non-operative form of  
management is appealing. Self-expanding metallic stents (SEMS) are an 
example of a relatively new technology that may allow surgery to be delayed or 
avoided completely in patients with obstructing colorectal cancer. 
This literature review serves to gather further information on the safety profile 
and efficacy of SEMS and their use in left-sided malignant colonic obstruction. 
The evidence found will be used to analyze the indications for the use of 
colonic SEMS. The information gathered from the international literature, will be 
used as a benchmark against which to measure our Groote Schuur Hospital 
experience with colonic SEMS (see Part C). 
2 Literature search method 
The literature search strategy involved a database search using Pubmed® 
(National Center for Biotechnology Information at the National Library of 
medicine located at the United States National Institutes of Health). The terms 
‘colonic stent’ and ‘colonic obstruction stent’ were used in this search.  This 
database includes MEDLINE® (Compiled by the United States National Library 
of Medicine). The references used by the review articles located by this search 
were further investigated. 
The search was limited to English language journal articles, human and adult 
articles that were found on the database. The initial Pubmed® search revealed 
376 journal articles. Journal articles that focused on SEMS placed for benign 
disease, SEMS placed in other areas of the gastrointestinal tract, 
radiographical features of SEMS and those comparing differing manufacturer’s 
SEMS types were excluded from the search. The time period for the search 
was limited from 1990 to 2009 as the first colonic SEMS was placed in 1991. 
Further important and randomized controlled trial articles were included in the 
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The journal articles found were stored in REFWORKS® for analysis. A total of 97 
articles underwent further abstract analysis. Eight review articles were among 
the 97 and their reference lists were analyzed and further relevant journal 
articles added for analysis. A total of 115 journal articles were assessed by 
abstract review. Some journal articles were disregarded if they were 
considered to be a repeat of information pertaining to a particular patient group 
at a particular hospital. The latest published article containing data from that 
hospital unit was included for analysis (7 studies). The table below (table 1) 
outlines the types and number of articles included in the study. 
Table 1: Types and number of articles included 
Type of article Number 
Retrospective case series 57 
Prospective studies 21 
Review articles 15 
Case reports 11 
Letter to the editor 1 
Randomized controlled trials (RCT) 6 
 
Studies that included greater than 30 patients were included for more 
extensive article review. This amounted to 23 studies, both retrospective and 
prospective and 15 review articles. All of the six randomized controlled trials 
(RCT) were included in the final analysis. 
3 Background: Extent of the colon cancer burden 
Colon cancer is the fourth most common type of cancer in the United States of 
America (USA)1. Colorectal cancer is the second commonest cause of cancer 
related death in the western world and there are over 30 000 new cases per 
year in the United Kingdom (UK)2. Annually, more than 945 000 people develop 
colorectal cancer worldwide, and around half a million patients die as a result3. 
Malignancies of the colon develop sporadically in the majority of cases, 
although less commonly their aetiology may be linked to inflammatory bowel 
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The majority of colorectal malignancies will present with non-specific 
symptoms such as anaemia, change in bowel habit, bleeding per rectum and 
abdominal discomfort. If appropriately screened with sigmoidoscopy or 
colonoscopy, the majority of patients with colorectal carcinoma should be 
detected early and referred for elective surgery as required. However, despite 
the introduction of colorectal cancer screening programmes, up to 20% of 
colorectal malignancies may still present as acute colonic obstruction4. Thus 
patients presenting with obstructing colorectal cancer remain a significant 
number and burden. 
According to Baron et al as much as 85% of emergency surgery for colonic 
obstruction may be ascribed to malignancy5. The remainder involves benign 
conditions (e.g. volvulus, diverticular disease) or other forms of malignancy 
(e.g. genitourinary cancers). 
South Africa currently has no national screening programme for colorectal 
cancer. Although the incidence of colorectal cancer is lower in Africa than in 
U.K or USA, there are certain population groups within South Africa that have a 
higher incidence. It is assumed that without a screening programme in South 
Africa there may be a higher number of patients that present with late stage or 
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4 Management options for obstructing colon cancer 
4.1 Surgery for left-sided obstructing colorectal cancer 
Until the early 1990’s surgery was the only method of relieving colonic 
obstruction. Right-sided colonic obstruction (obstruction proximal to the 
hepatic flexure) is dealt with straightforwardly by a right hemicolectomy with a 
primary ileal to distal non-dilated colon anastomosis.  In contrast, surgery for 
left-sided colonic obstruction is more complicated.  Surgery for left-sided 
colonic obstruction is fraught with more difficulty and has a greater risk of 
anastomotic breakdown due to the dilated friable colon proximal to the 
obstruction that provides poor tissue for anastomoses6. In addition, electrolyte 
imbalances, nutritional compromise and faecal loading all contribute to an 
increased risk of anastomotic failure.  Patients with malignant large bowel 
obstruction are clearly poor surgical candidates and mortality rates can reach 
up to 30%4,7,8. 
Due to the above difficulties encountered with surgery for left-sided colonic 
obstruction and the risk of anastomotic leaks, initial surgery aimed to avoid an 
intra-abdominal anastomosis. Historically a “three-stage” operation was 
described. This encompasses three separate visits to theatre. The first 
operation is a decompressive stoma while the primary cancer is left in situ. The 
second surgery involves resection of primary tumour. Finally, the patient 
returns to theatre for closure of the stoma. The five-year survival for those 
patients completing all three operations was 19-38%4. 
The morbidity of the three-stage surgery motivated surgeons to attempt “two-
stage” procedures4. A “two-stage” procedure includes a resection of the 
obstructing lesion with closure of the distal colon/rectum and an end 
colostomy proximal to the lesion.  Re-establishment of bowel continuity is 
perfomed electively. This has led to shorter hospital stays than with three-stage 
surgery although up to 60% of patients never have their stomas reversed7. 
“One-stage” surgery involves primary resection of the colonic tumour and 
primary anastomosis.  This is done either via total colonic resection with 
ileorectal anastomosis or segmental resection with on-table colonic lavage for 
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stage surgery in terms of morbidity and mortality9 but studies in this area are 
non-randomized and thus open to bias of patient choice and procedure 
choice. 
On-table colonic lavage is contentious. A prospective randomized study of 
elective colonic resection comparing bowel preparation to no bowel 
preparation failed to show a decrease in the risk of leakage or infection10, 
however it is difficult to extrapolate these results to the emergency surgery 
setting. 
Emergency surgery has high morbidity (40-50%7) and mortality rates11. These 
rates are significantly higher than the 5% mortality in the elective situation11 
and emergency surgery often results in stoma creation. 
Stoma formation has a negative impact on quality of life12. Colostomy 
formation has a morbidity rate of up to 34%13. Many patients are unable to 
undergo reversal of colostomy on basis of advanced age and co-morbidities 
and thus remain with a permanent stoma4. Some studies quote that 60% of 
these patients never go on to have stoma reversal4,14. The concept of a non-
operative management that avoids stoma formation is certainly attractive. 
 Innovative non-surgical techniques 
4.1.1 Decompression tubes 
Along the historical timeline between surgery and colonic stents, 
decompression tubes were developed. These were and still are used by some 
centres to relieve colonic obstruction while avoiding emergency surgery. 
Endoscopically placed decompression tubes have been employed as a 
temporizing measure to relieve large bowel malignant obstruction15.  The tubes 
are used to decompress the colon thereby decreasing the risk of perforation 
and allow for preoperative bowel preparation. It is relatively inexpensive. 
Decompression tubes are placed by manual advancement over an 
endoscopically or fluoroscopically placed guide wire. The disadvantages are 
that it can be time consuming to place, is only a temporary measure and is not 
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4.1.2 Laser therapy  
Another technological advancement has been the use of laser. It has been 
used mostly for palliation of rectosigmoid cancers. The largest published series 
of 272 patients documented the 14-year experience from France of patients 
undergoing palliative therapy for rectosigmoid cancers17. There was a high 
immediate success rate in treating obstructive symptoms (85%) and a low 
major complication rate (2%)17. These figures likely reflect on the large 
experience of the reporting treating endoscopists. Laser is effective for distal 
lesions but technically difficult for tumours proximal to the sigmoid colon. 
Disadvantages of laser therapy include: the requirement of specialized 
treatment rooms with special precautions to protect the operator and the 
assistants and the fact that multiple treatment sessions are often required. The 
smoke generated during the ablation procedure also limits the visibility thus 
increasing the possibility of perforation18. 
4.1.3 Balloon dilatation 
Balloon dilatation has been used, particularly in conjunction with SEMS 
placement, but appears to be associated with a higher risk of perforation than 
with just SEMS placement alone19. 
4.1.4 Self-expanding metal s ents for the colon 
Over the last two decades, great advances have been made in the ability to 
palliate malignant obstruction throughout the gastrointestinal tract. SEMS are 
in routine use for malignant oesophageal, gastroduodenal and biliary 
obstruction. The first report of the successful placement of a rectal stent was 
published by Dohomoto in 199120. 
The appeal of endoscopic management rather than surgery is that high risk 
patients avoid surgery and the risks associated with anaesthesia. Another 
advantage of colonic stent placement done preoperatively is to allow for a 
preoperative colonoscopy to exclude synchronous lesions21. In Vitale’s series, 
a synchronous cancer was detected in three patients (9.6% of his series) 
hence changing the initial surgical plan21. 
SEMS have been used in two separate groups of patients. The first is the 
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by Tejero et al22 to describe a group of patients who underwent successful 
decompression following colonic stent placement allowing time for a thorough 
clinical evaluation and for the patient to be staged before surgery23. SEMS 
placement in the colon has also been used in a second group of patients as 
effective palliation. In incurable patients with metastatic disease SEMS have 
been used as definite treatment. The risks of surgery are thus avoided. SEMS 
have been shown to provide durable palliation and improved quality of life over 
their counterparts undergoing emergency surgery and stoma creation24,25. 
A meta-analysis comparing colonic SEMS and open surgery showed that 
colonic stenting was effective palliation for malignant colonic obstruction26. 
SEMS were associated with a lower length of hospital stay and low rate of 
stoma formation; however there was no difference in overall survival between 
those patients with stents who undergo subsequent resection and those 
undergoing emergency surgery26. 
A few studies advocate that colonic stent placement need not be limited to 
tertiary centres. A study analyzing stent placement in a community hospital 
(Oshawa, Ontario Canada) showed that all meaningful parameters were 
comparable to those from tertiary centres27. Baerlocher and colleagues had a 
stent success rate of 91.3% and a complications rate of 18%. A study from the 
Countess of Chester Hospital in the U.K. showed a success rate of 78% and a 
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4.2 Self-expanding metallic stents: further discussion 
4.2.1 Technique of SEMS placement 
SEMS can be placed in the colonoscopy suite. Minimal sedation, as is given 
during routine screening colonoscopy, is all that is required for stent 
placement. Colonic SEMS can be placed under fluoroscopic or 
endoscopic/fluoroscopic guidance. There are no randomized clinical data 
formally comparing the two methods29. The endoscopic/fluoroscopic method 
of stent placement involves visualizing the obstructing tumour through a 
colonoscope. A guide wire is passed down the scope and across the bowel 
tumour and a catheter passed over the wire. This is all done under radiological 
screening. Contrast is injected through the catheter in order to confirm the 
position within the lumen of the bowel to ensure no perforation and to identify 
the upper limit of tumour. The stent is then railroaded over the guide wire and 
across the lesion.  It is deployed using a specialised delivery system. It slowly 
expands creating a 1-2cm lumen. In contrast to decompression tubes, stents 
have potential to dilate obstructed colon to near-normal luminal diameter30. 
Colonic SEMS can be placed across lesions longer than the length of a single 
stent. Decompression is achieved by placing more than one stent and allowing 
the ends of the stents to overlap6. 
4.2.2 Complications of colonic self-expanding metallic stents 
Colonic SEMS are not without complications. Stool in large bowel is often solid 
and there is thus greater potential for SEMS to block compared to biliary tree 
or oesophageal stents. Obstruction rates vary and are often divided into early 
(<30 days) or late (>30days) obstruction. Colonic stents may become impacted 
with stool, particularly if long stents or multiple devices are used56. SEMS can 
also kink or fracture. Tumour ingrowth and overgrowth can cause obstruction 
of SEMS. Covered SEMS have been developed to counter tumour ingrowth but 
cannot prevent overgrowth. 
Stent migration either during deployment or later can be problematic. Self-
expanding metallic stents may migrate and lodge in the rectum, causing 
tenesmus and require removal64. Stents have also been placed for benign 
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the benign condition, which when started allows the inflammation causing the 
obstruction to settle64. Migration can also occur after tumour regression 
following radiation therapy65. This however, is not always clinically significant if 
the patient remains unobstructed. 
Perforation of the colon may be due to the guide wire used for placement or 
due to stent expansion. Procedure related perforation is most likely to occur 
when dilatation of the tumour lumen is performed prior to stent insertion and 
this practice is not advised43. Pre-deployment dilatation has shown to increase 
the risk of perforation and tumour fracture5. 
Experience is limited but patients with SEMS tolerate subsequent radiation and 
chemotherapy without increased incidence of complications66. Prior radiation 
therapy, however, increases the risk of bleeding and perforation because of 
inherent tissue weakness and poor vascularity. The evidence for this is largely 
extrapolated from the experience gained with oesophageal stents67,68 but it is 
still important to consider when using colonic SEMS. 
Post procedure pain, bleeding and tenesmus are most commonly seen with 
rectal lesions. The device has to be removed if the symptoms are intractable. 
Stents are expensive although not as costly as surgery. Self-expanding metallic 
stents range from R5800-R8000 each (Wallstent® Boston Scientific) and can 
only be placed by medical professionals with specialized training29. If surgery is 
avoided and a stoma is not required then the use of colonic SEMS become a 
cost-effective measure. 
There is one retrospective study32 that found that the insertion of SEMS as a 
bridge to surgery in left-sided colonic obstruction had an adverse effect on the 
overall 5-year survival rate. The SEMS group was matched with patients who 
underwent elective surgery for non-obstructing tumours. It is unclear whether 
this adverse effect is thus related to the emergency presentation of obstruction 
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4.2.3 Existing evidence for colonic stents 
The ideal results would be that placement of SEMS can be shown to reduce 
immediate mortality and morbidity without compromising long-term survival. 
Thus far, however, data to comprehensively answer these questions has been 
lacking. Further analysis of the available data was undertaken in an attempt to 
provide clarity on the safety and efficacy of SEMS used for colonic obstruction. 
A total of 23 prospective and retrospective case series that had patient 
numbers over 30 were included for assessment  (table 2). The data captured 
included: year of study, whether retrospective or prospective, country of origin, 
total number of patients included in the study, stent success rate, reason for 
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Table 2: Colonic Stent Study Data 





























































Athreya19 2006 Retrospective UK 102 90 12 87 0 4 5 2 
Baraza31 2008 Prospective UK 63 56 7 57 0 0 6 8 
Kim32 2009 Retrospective Korea 35 7 28 35 - - - - 
Garcia-Cano33 2006 Retrospective Spain 175 66 72 162 2 7 7 3 
Li34 2009 Prospective China 52 0 50 50 0 0 4 1 
Soto35 2006 Retrospective Spain 62 40 22 58 0 3 7 0 
Shrivastava36 2008 Retrospective UK 91 - - 81 0 10 7 3 
Stenhouse37 2008 Prospective UK 72 56 16 68 1 2 14 - 
Suzuki38 2004 Retrospective UK 42 34 2 36 0 2 7 5 
Repici39 2008 Prospective Italy 42 23 19 39 0 1 1 7 
Ptok40 2006 Prospective Germany 48 48 0 44 0 0 7 3 
Mucci- Hennekinne41 2007 Retrospective France 67 55 12 62 0 2 3 8 
Martinez- Santos14 2002 Prospective Spain 43 17 24 41 0 0 0 2 
Im42 2008 Prospective Korea 49 49 0 49 0 2 3 9 
Alcantara43 2007 Prospective Spain 95 28 67 90 0 4 4 4 
Vemulapalli44 2009 Retrospective USA 53 53 0 50 0 6 4 4 
Meisner45 2004 Prospective Denmark 96 51 37 88 0 0 8 6 
Law46 2003 Retrospective China 30 30 0 29 0 1 3 0 
Watson47 2005 Retrospective UK 103 83 10 93 3 2 4 3 
Camunez48 2000 Retrospective Spain 80 42 38 67 1 4 3 2 
Mainar49 1999 Retrospective Spain 71 0 71 64 0 1 0 0 
Fregonese50 2008 Retrospective Europe 36 1 34 35 0 3 1 2 
Jost51 2007 Retrospective Switzerland 67 22 45 59 1 3 6 14 
TOTAL 1615   1482 8 57 104 86 










Part B: Literature Review 
 24 
 
A combined total of 1615 patients were enrolled in the 23 studies reviewed. All 
studies were undertaken in northern hemisphere countries and the majority of 
studies were retrospective (60%). The studies were published between 2002 
and 2009. The technical combined success of colonic stent placement was 
92% (range 83-100%). This series review had a mortality of 0.5% and a 
perforation rate of 3.8%. The overall complication rate of SEMS placement or 
attempted placement was 16%. 
Endoscopic stenting tends to produce lower mortality rates than urgent 
surgical intervention9 and analysis of the data presented in table 2 would 
support this statement. 
Published review articles of colonic SEMS usage show similar positive results. 
Khot et al52 and Sebastian et al53 reviewed results in patients treated with 
SEMS. See table 3 for a summary of results of these two aforementioned 
reviews. 
Table 3: Results of review articles by Khot and Sebastian 
 Khot et al53 Sebastian et al54 
Technical success 88% 91% 
Mortality 1% 0.6% 
Perforation rate 4% 3.8% 
 
The perforations in these two series were noted to be associated with balloon 
pre-dilatation of the strictures. 
SEMS have been shown to reduce morbidity and mortality as well as the need 
for a permanent colostomy29. SEMS used to relieve colonic obstruction have 
been shown to be cost effective54. Cost saving is due in part to shorter hospital 
stays, fewer surgical procedures, reduced operating room time and fewer days 
in intensive care. The cost of stoma care and disposable stoma bags is a 
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Stipa et al57 reported that after successful SEMS placement and colonic 
decompression, open or laparoscopic surgery was possible. The presence of a 
stent did not adversely affect laparoscopic resection. 
4.2.3.1 Randomized	  controlled	  trial	  data	  
In conflict to the above data on colonic stent placement is the data emerging 
from attempted randomized controlled trials. Three attempts (two from one 
centre) at randomized controlled trials have had to be terminated early due to 
concern over complications in the patient groups receiving colonic stents58,59,60. 
Van Hooft and colleagues have attempted two separate trials aiming to assess 
whether colonic SEMS were superior to surgical treatment. Both trials were 
terminated early by the safety monitoring committee due to a high number of 
unexpected adverse events (particularly stent related perforations) in the non-
surgical/SEMS arm. The reasons offered for the high unexpected perforation 
rate were that perhaps the unexpected adverse events were specifically related 
to the type of stent or type of chemotherapy used. 
Pirlet and colleagues58 attempted a RCT where patients were randomized to 
emergency surgery or to the use of SEMS as a bridge to surgery. The trial was 
also terminated early due to a high number of complications and a high stoma 
rate in the patient group receiving stents. 
Cheung and colleagues61, however, report conflicting results in their RCT.  This 
RCT from China concludes that colonic SEMS can be safely placed in bridge 
to surgery patients and allows these patients to avoid the morbidity of a stoma. 
Another RCT62 found enrolled only 22 patients for palliative treatment of 
malignant rectosigmoid obstruction. They concluded there were no statistically 
significant differences between the surgery and stent group in terms of 
morbidity and mortality. 
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Table 4: Summary of Randomized Controlled Trial Data 


























































Van Hooft59* 2011 Netherlands 98 47 51 33 9 6 - - 
Van Hooft60* 2006 Netherlands 21 11 10 - 3 4 - - 
Cheung61 2009 China 48 24 24 20 0 0 0 0 
Pirlet58* 2011 France 67 35 32 14 0 3 0 0 
Fiori62 2004 Italy 22 11 11 11 0 0 0 0 
Xinopoulos63 2004 Greece 30 15 15 14 0 0 1 6 
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4.3 South African experience of colon stent usage 
The National Cancer Registry of South Africa reported in 2003 that the 
cumulative lifetime incidence risk (0-74 years) of colorectal cancer was 1.07 
making colorectal cancer the fifth commonest malignancy encountered in 
South Africa. 
Although there are no South African studies available, data on colonic stent 
usage was obtainable from Boston Scientific, a company, which had the 
largest market share for colonic stents in South Africa during the time period 
2006–2009 (figure 2). 
 
 
Figure 2: Numbers of Boston Scientifiic Colonic Stents used per year in South Africa 
The majority of SEMS are currently being utilized in the public sector in South 
Africa. Other than 2007, Groote Schuur Hospital, SEMS usage comprised 
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5 Conclusion 
Research conducted in the area of SEMS in the colon is rapidly evolving and in 
time it is likely that there will be enough data to conclusively make 
recommendations and draw up comprehensive guidelines for the usage of 
colonic SEMS. At this stage further well-structured randomized controlled trials 
are needed. Of concern is that three of the RCT’s attempted have been 
terminated early due to complications in the SEMS group. This casts a shadow 
over the pooled data extracted from prospective and retrospective reviews that 
overwhelmingly seems to favour SEMS placement over emergency surgery in 
terms of morbidity and mortality. More studies focusing on the long term 
impact and complications of colonic stents are required. The impact and safety 
of SEMS placed in patients undergoing chemotherapy and radiotherapy needs 
to be further investigated. There is still concern that tumour perforation by 
stents may worsen patient prognosis but there appears to be no good 
evidence available to confirm or refute this. 
There is at present no truly robust level I evidence in the realm of colonic 
SEMS. There appears to be no published South African literature or literature 
from elsewhere in Africa covering colonic SEMS. A South African cost 
effectiveness study would be beneficial as it is difficult to apply data extracted 
from elsewhere to our situation. 
Colonic self-expanding metallic stents are a promising management tool in the 
battle against obstructing colon cancer. It would be unwise to encourage the 
widespread use of SEMS without, as with any new technology, careful 
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Colonic self-expanding metallic stents (SEMS) are proven to be safe and 
effective in the management of selected cases of malignant colonic 
obstruction. Since 2005, we have used endoscopic decompression with SEMS 
as the primary treatment of all patients with left-sided obstructing colorectal 
cancer, in the absence of perforation. The purpose of the study was to assess 
the safety and efficacy of this management protocol. 
Method 
This is a study of consecutive patients who presented to our unit with left-
sided obstructing colorectal cancer between January 2005 and June 2009. 
Patients were excluded if there was clinical or radiological suspicion of bowel 
perforation. Emergency surgery was offered to those patients in whom colonic 
stent placement failed. After successful decompression, surgery was offered to 
those patients who were found t  have potentially curable disease. 
Results 
Seventy-eight patients presented to the unit during the study period. Protocol 
was not followed in one patient. SEMS were successfully placed in 60/77 
patients (78%). In 35 patients, SEMS served as their definitive palliative 
treatment while in 25 patients, SEMS were placed as a bridge to surgery. 
Overall, 32/35 (91%) of patients in whom stents were successfully placed for 
palliation avoided surgery. Fifteen out of 17 patients, in whom SEMS 
placement failed, underwent emergency surgery. Stomas were fashioned in 
5/60 patients who were successfully stented, and 12/17 (71%) patients in 
whom stenting failed (p=0.0001). Five of the 60 successfully stented patients 
(8%) and 3/17 (18%) in the failed stent group died (p=0.3644). All deaths in the 
successfully stented group were due to advanced metastatic disease. Eight 
patients had complications related to SEMS.  No patients died from 













In our unit, SEMS placement for left-sided malignant colonic obstruction could 
be performed safely, with a low mortality and complication rate, and allowed 













What is New in this Paper? 
The patients that underwent attempt stent placement included all patients 
presenting with left-sided obstructing colorectal cancer that presented to one 
colorectal unit. The study is not limited to selected patients that may be 
considered easier to stent i.e. lower sigmoid cancers or shorter duration of 
obstructive symptoms. 
Introduction 
Left-sided obstructing colorectal cancer has traditionally been managed with 
emergency surgery although not without significant accompanying morbidity 
and mortality1.  Patients presenting with malignant large bowel obstruction are 
more likely to present with metastatic disease and have a poorer 5 year 
survival2. 
Colonic self-expanding metallic stents (SEMS) have been advocated as an 
alternative method of achieving decompression of colonic obstruction whilst 
avoiding the physiological strain associated with emergency surgery.  SEMS 
have been used as both definitive palliative treatment3 of malignant obstruction 
and as a temporizing form of decompression prior to definitive surgery (‘bridge 
to surgery’) 4. 
In case series of selected patients with left-sided malignant colonic 
obstruction, SEMS have been shown to be effective in achieving 
decompression with good technical and clinical success rates5,6. These series 
also report low complication rates suggesting that SEMS can be considered a 
safe alternative to surgery. 
As colonic SEMS become more widely used it is important to consider whether 
SEMS should be applicable to all patients with left-sided obstructing colorectal 
cancer or only to select patients. Since 2005, our colorectal unit adopted a 
protocol (figure 1) of endoscopic decompression with SEMS as the primary 
treatment of all patients presenting with left-sided obstructing colorectal 
cancer, without evidence of perforation. The purpose of the study was to 













This is a study of consecutive patients with left-sided obstructing colon 
carcinoma. All patients who presented to the Colorectal Surgery Unit at Groote 
Schuur Hospital (a university referral hospital in Cape Town, South Africa) with 
left-sided large bowel obstruction due to primary colorectal cancer between 
January 2005 and June 2009 were considered for enrollment in the study. Only 
patients with obstructing lesions from the hepatic flexure proximally to the 
upper third of the rectum distally were included.  Patients with more proximal 
lesions were offered emergency surgery. All lesions were biopsied and 
confirmed to be adenocarcinoma on histology. 
All patients had clinical and radiologic evidence of large bowel distension, and 
in all cases the lumen at the site of obstruction was too narrow to pass a 
colonoscope through it. Patients were included regardless of whether there 
was evidence of metastatic disease at the time of presentation. 
In accordance the unit protocol (figure 1), patients were excluded if there was 
clinical (signs of peritonitis or sepsis) or radiological evidence (single contrast 
water soluble enema or abdominal computed tomography scan) of bowel 
perforation or peritonitis. These patients were offered emergency surgery. 
Eligible patients were offered decompression of the colon using SEMS as the 
primary procedure. The procedure was performed in the endoscopy suite 
under conscious sedation or with the patient awake, depending on the level of 
discomfort during the procedure. The stents were placed by endoscopists with 
experience at placing colonic SEMS. No anaesthetist or radiologist was 
involved at the time of stent placement. 
In all cases a guide wire was passed through the obstructing lesion via an 
endoscope, a catheter was passed over the guide wire, and water soluble 
contrast was introduced through the catheter to confirm its position to be 
intraluminal. The guide wire was then re-introduced, the SEMS was passed 
over the guide wire across the lesion, and deployed under radiological and 
endoscopic control. Boston Scientific® colonic stents were used in all cases. 
Post procedure, abdominal and erect chest x-rays were performed to confirm 












SEMS insertion was considered to be successful if the stent was correctly 
deployed across the lesion, and if the bowel was decompressed both clinically 
and radiologically. If the stent was not successfully deployed, emergency 
surgery was offered. Emergency surgery was also offered for complications of 
SEMS placement where appropriate. 
After successful decompression by SEMS and radiological staging of the 
malignancy, patients with potentially curable disease who were fit for surgery 
were offered elective resection (‘bridge to surgery’). In patients with incurable 
disease, the stent was the definitive palliative procedure, and resection was not 
routinely offered (‘palliative group’). The patients were described as being in 
the ‘palliative’ or ‘bridge to surgery group’ after staging. For example, a patient 
who was found to have unsuspected peritoneal metastases at the elective 
operation would still be considered to be in the ‘bridge to surgery group’. 
Statistical analysis 
Actuarial survival was calculated using the Kaplan-Meier technique. 
Continuous data were compared using Student’s t-test, and ordinal data using 
the chi-square test. A P-value of ≤ 0.05 was regarded as significant. 
Ethical approval 
All patients gave informed consent for the procedures undertaken. The study 
















During the four and a half year study period, 78 patients presented with left-
sided colonic obstruction due to colorectal adenocarcinoma. In one case, 
protocol could not be followed and SEMS was not attempted, as there was no 
endoscopist capable of inserting SEMS available on that day. This patient was 
excluded from the study, leaving 77 patients in whom SEMS insertion was 
attempted. The ages, gender ratio and site of the tumour are presented in table 
five. 
Reasons for stent, technical success and immediate complications 
SEMS was successfully placed in 60/77 (78%) of cases. Of the cases where 
SEMS were successfully placed, 25/60 (42%) were placed as a ‘bridge to 
surgery’, and 35/60 (58%) were placed for palliation. Perforation of the bowel 
during SEMS insertion occurred in one case (1.3%). This was recognized 
immediately, and the patient underwent an emergency Hartmann’s procedure 
and had an uneventful post-operative course. There was one guide wire 
perforation that was detected immediately. The patient still had a stent 
successfully placed with no adverse outcome. There were no other immediate 
complications of SEMS placement. Five of 60 (8%) patients died within 30 
days of successful SEMS insertion. All of these patients died of extensive 
metastatic disease, and there were no deaths due to complications of stent 
placement. 
Bridge to surgery group 
Of the 25 patients who had SEMS placed as ‘bridge to surgery’, ten underwent 
attempted laparoscopic resections (with three conversions to open 
procedures), and 14 had open operations. The decision on the type of surgery 
offered was left to the discretion of the operating surgeon. There were no peri-
operative deaths. 
One patient declined surgery despite being fit for the procedure and having no 
evidence of metastatic disease at that time. She died eighteen months later of 
metastatic disease. One patient had extensive peritoneal metastases (that had 












planned resection was abandoned, and the stent left in situ for palliation. Three 
of the 25 (12%) patients in this group had stomas. These were temporary loop 
ileostomies in patients who underwent low anterior resections for upper third 
rectal lesions. 
Palliative group 
SEMS were placed for palliation in 35 patients (34 had incurable metastatic 
disease, and one was unfit for surgery).  The median survival after SEMS for 
palliation was four months. The longest survivor was still alive at his most 
recent follow up after 22 months. Six patients developed long-term 
complications after SEMS. Stent migration occurred in two patients. One of 
these developed recurrent obstruction, and was successfully re-stented. The 
other passed the stent per rectum and then remained unobstructed until his 
death from metastatic disease. One patient with a rectal tumour developed 
tenesmus, and underwent a Hartmann’s resection of the tumour. Three 
patients developed obstruction at the site of stent due to tumour ingrowth or 
kinking of the stent. One of these patients was successfully re-stented, one 
had a loop colostomy fashioned, and the other patient who presented with 
stent blockage developed nosocomial pneumonia and died before any surgical 
intervention. Overall, 32/35 (91%) of patients in whom stents were successfully 
placed for palliation avoided surgery. 
Failed stents 
Attempted stent placement failed in seventeen patients. Reasons for the 
failures included inability to visualise the lumen, inability to pass the guide wire 
across the lesion, excessive angulation of the colon, fixity of the colon and 
inability to visualise the tumour. Two patients were considered unfit for surgery 
due to advanced malignancy and severe comorbidities, and died within a week 
after the procedure was attempted. The other 15 patients all underwent 
emergency surgery. The operations performed are summarized in table 6. One 
of these patients had extensive peritoneal carcinomatosis. It was not 
technically possible to mobilize the bowel sufficiently to give her a colostomy, 
and she died one week post surgery. There were no other peri-operative 
deaths in the failed SEMS group, so in total 3/17 (18%) died in this group. 












who were successfully stented and those in whom stenting failed (5/60 [8%] 
vs. 3/17[18%], p=0.51). 
Stomas 
Stomas were fashioned in 2/35 (6%) patients in the palliative group (both 
permanent), and 3/25 (9%) patients (temporary) in the bridge to surgery group. 
Among the patients who underwent surgery due to failed stenting, 12/17 (71%) 
had stomas created (10 were permanent, and two temporary). Successful 
SEMS placement was associated with a lower rate of stoma formation in both 
the palliative (P<0.0001) and bridge to surgery (P=0.0001) groups when 
compared with the failed SEMS group. 
Discussion 
In this series of consecutive patients with left-sided colonic obstruction due to 
colorectal cancer, SEMS could be placed with a high success rate (78%) in 
relieving obstruction and with an acceptably low complication rate. The results 
of this study compare satisfactorily with other non-randomized prospective 
studies of selected patients that find colonic SEMS to be safe and effective7 
with a low morbidity and mortality6,8. These studies, however, have a higher 
clinical stent success rate (90-94%). Our lower success rate (78%) can be 
attributed to the adherence to the protocol of attempting to primarily stent all 
patients with left-sided colonic obstruction. No attempts were made before the 
procedure to identify whether the patients were good candidates for stents or 
whether the patients has favourable tumour morphology for stenting. 
Successful SEMS placement allowed the majority of patients in our series to 
avoid the morbidity of a stoma. These results compare favorably with other 
small single centre randomized controlled trials showing SEMS to be safe and 
to have a lower stoma rate than in patients undergoing emergency surgery9,10. 
Colonic stents have allowed patients undergoing palliative treatment to avoid 
surgical intervention11. In the palliative setting, our results showed that SEMS 
allowed the majority of patients in this group (91%) to avoid any surgery. 
Although safety concerns have been raised by the preliminary results and early 
termination of recent multicenter randomized controlled trials12,13, the low 












Although our data is not randomized, which limits our study, our patient group 
was not a select group of patients considered suitable for colonic SEMS but 
rather attempted placement of stents was done in all patients that fulfilled the 
unit protocol criteria. Another consideration is that the majority of our patients 
due to cost constraints received systemic 5-fluorouracil and leucovorin as the 
primary chemotherapeutic regime. It is unsure whether more aggressive 
chemotherapeutic regimes (e.g. addition of oxaliplatin or irinotecan) may incur 
a higher stent-related perforation rate. 
We conclude that in our unit, stents are an effective and safe method of 
managing left-sided obstructing colorectal cancer in palliative as well as bridge 

































    









Gender ratio (M:F) 7:10 14:11 19:16 
Median (range) age 
(years) 
60 (31-81) 62 (26-84) 69 (36-95) 
Site of tumour    
 Splenic flexure 2 1 3 
 Descending colon 4 4 1 
 Sigmoid colon 8 13 16 
 Rectosigmoid 3 7 14 
 Rectum 0 0 1 
     





















Defunctioning stoma (no 
resection) 
8 (47%) 0 1 (3%) 
Resection and temporary stoma 2 (12%) 3 (2%) 0 
Resection and permanent stoma 2 (12%) 0 2 (6%) 
Resection and primary 
anastomosis (no stoma) 
2 (12%) 20 (80%) 0 
Laparotomy only 1 (6%) 1 (4%) 0 
No surgery 2 (12%) 1 (4%) 32 (91%) 
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